OPAL K

OPAL K is a bioactive natural extract derived from the ripe fruit of *Carica papaya* (papaya), developed by the Australian biopharmaceutical company Phoenix Eagle using their proprietary OPAL technology. This technology is designed to preserve chemical entities in the fruit that typically degrade rapidly. OPAL K is intended for topical application to manage complex wounds, including infected stage-4 pressure ulcers and other chronic wounds. Its mechanism of action involves papaya-derived proteolytic enzymes, specifically cysteine and serine proteases, which aid in wound debridement. Additionally, the extract exhibits vasodilatory, anti-inflammatory, and antibacterial properties that support infection management and the overall healing process in dermal ulcers.

Other names

Carica papaya extract